Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12

• Published in: Journal of clinical immunology 2023-10, Vol.43 (7), p.1543-1556
• Main Authors: Walker, Kieran, Mistry, Anoop, Watson, Christopher M., Nadat, Fatima, O’Callaghan, Eleanor, Care, Matthew, Crinnion, Laura A., Arumugakani, Gururaj, Bonthron, David T., Carter, Clive, Doody, Gina M., Savic, Sinisa
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing - metabolism; AKT protein; Antigens, CD19 - genetics; Antigens, CD19 - metabolism; B-Lymphocytes; Biomedical and Life Sciences; Biomedicine; CD19 antigen; CD40L protein; Cell activation; Cell differentiation; Cell surface; Chemokine CXCL12 - genetics; Chemokine CXCL12 - metabolism; CXCL12 protein; CXCR4 protein; Flow cytometry; Humans; Hypogammaglobulinemia; Immunodeficiency; Immunoglobulins; Immunological memory; Immunology; Infectious Diseases; Internal Medicine; Localization; Lymphocytes B; Medical Microbiology; Memory cells; Ontogeny; Original; Original Article; Phosphorylation; Plasma; Plasma cells; Plasma Cells - metabolism; Primary immunodeficiencies; Proto-Oncogene Proteins c-akt - metabolism; Receptors, Antigen, B-Cell; Western blotting
• ISSN: 0271-9142; 1573-2592; 1573-2592
• DOI: 10.1007/s10875-023-01511-w

Background The human CD19 antigen is expressed throughout B cell ontogeny with the exception of neoplastic plasma cells and a subset of normal plasma cells. CD19 plays a role in propagating signals from the B cell receptor and other receptors such as CXCR4 in mature B cells. Studies of CD19-deficient patients have confirmed its function during the initial stages of B cell activation and the production of memory B cells; however, its role in the later stages of B cell differentiation is unclear. Objective Using B cells from a newly identified CD19-deficient individual, we investigated the role of CD19 in the generation and function of plasma cells using an in vitro differentiation model. Methods Flow cytometry and long-read nanopore sequencing using locus-specific long-range amplification products were used to screen a patient with suspected primary immunodeficiency. Purified B cells from the patient and healthy controls were activated with CD40L, IL-21, IL-2, and anti-Ig, then transferred to different cytokine conditions to induce plasma cell differentiation. Subsequently, the cells were stimulated with CXCL12 to induce signalling through CXCR4. Phosphorylation of key downstream proteins including ERK and AKT was assessed by Western blotting. RNA-seq was also performed on in vitro differentiating cells. Results Long-read nanopore sequencing identified the homozygous pathogenic mutation c.622del (p.Ser208Profs*19) which was corroborated by the lack of CD19 cell surface staining. CD19-deficient B cells that are predominantly naïve generate phenotypically normal plasma cells with expected patterns of differentiation-associated genes and normal levels of CXCR4. Differentiated CD19-deficient cells were capable of responding to CXCL12; however, plasma cells derived from naïve B cells, both CD19-deficient and sufficient, had relatively diminished signaling compared to those generated from total B cells. Additionally, CD19 ligation on normal plasma cells results in AKT phosphorylation. Conclusion CD19 is not required for generation of antibody-secreting cells or the responses of these populations to CXCL12, but may alter the response other ligands that require CD19 potentially affecting localization, proliferation, or survival. The observed hypogammaglobulinemia in CD19-deficient individuals is therefore likely attributable to the lack of memory B cells.